News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,205 Results
Type
Article (14963)
Company Profile (299)
Press Release (266937)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79950)
Career Advice (162)
Deals (13362)
Drug Delivery (39)
Drug Development (50902)
Employer Resources (32)
FDA (5874)
Job Trends (5175)
News (145409)
Policy (10117)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (925)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21786)
ALS (124)
Alzheimer's disease (1036)
Antibody-drug conjugate (ADC) (241)
Approvals (6071)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4567)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (343)
Cancer (3130)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43817)
Collaboration (1148)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4326)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1379)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31683)
Editorial (25)
Employer branding (4)
Employer resources (30)
Events (51776)
Executive appointments (621)
FDA (7626)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (980)
Gene editing (182)
Generative AI (21)
Gene therapy (488)
GLP-1 (504)
Government (1151)
Grass and pollen (3)
Guidances (166)
Healthcare (6638)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1204)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7352)
IRA (12)
Job creations (869)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1404)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2663)
Medtech (2672)
Mergers & acquisitions (6632)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (232)
Neuropsychiatric disorders (70)
Neuroscience (1964)
Neurotech (1)
NextGen: Class of 2026 (2056)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (239)
Partnered (12)
Patents (302)
Patient recruitment (327)
Peanut (43)
People (26678)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15538)
Phase 2 (20377)
Phase 3 (12867)
Pipeline (3249)
Policy (90)
Postmarket research (853)
Preclinical (6550)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (652)
Real estate (1452)
Recruiting (13)
Regulatory (9937)
Reports (19)
Research institute (973)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (346)
Last 30 days (1210)
Last 365 days (17838)
2026 (1657)
2025 (18131)
2024 (20582)
2023 (22462)
2022 (26920)
2021 (27894)
2020 (23414)
2019 (16263)
2018 (11773)
2017 (13775)
2016 (11871)
2015 (14376)
2014 (10407)
2013 (7503)
2012 (7544)
2011 (7621)
2010 (7445)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18322)
Australia (3113)
California (7080)
Canada (1836)
China (774)
Colorado (246)
Connecticut (253)
Delaware (235)
Europe (39272)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (399)
India (35)
Indiana (160)
Iowa (8)
Japan (229)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5581)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1651)
New Mexico (13)
New York (1760)
North Carolina (825)
North Dakota (6)
Northern California (3478)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1301)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2807)
Tennessee (40)
Texas (908)
United States (23369)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,205 Results for "lysosomal therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™
February 5, 2026
·
15 min read
Press Releases
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
February 5, 2026
·
17 min read
Press Releases
Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
December 16, 2025
·
4 min read
Press Releases
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
November 13, 2025
·
3 min read
Press Releases
GC Biopharma’s Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal
August 21, 2025
·
3 min read
Press Releases
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
June 19, 2025
·
5 min read
Press Releases
M6P Therapeutics to Host Virtual KOL Event to Discuss the Lysosomal Storage Disorders Treatment Landscape on April 22, 2025
April 9, 2025
·
4 min read
Press Releases
Mair Therapeutics Announces Scientific Collaboration with Radboud University to Advance TMEM175 Agonists for Parkinson’s Disease
January 27, 2026
·
2 min read
Press Releases
Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
January 14, 2025
·
10 min read
Press Releases
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 5, 2026
·
7 min read
1 of 28,221
Next
